CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Guizhou Bailing Group Pharmaceutical Company Limited Company Snapshot
Guizhou Bailing Group Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guizhou Bailing Group Pharmaceutical Company Limited with three other companies in this sector in CHINA : Xiangxue Pharmaceutical Co Ltd (2019 sales of 2.79 billion Chinese Renmimbi [US$399.57 million] of which 49% was Chinese Herbal Medicines), Gan & Lee Pharmaceuticals Co Ltd (2.89 billion Chinese Renmimbi [US$415.02 million] of which 97% was Insulin and related products), and Sihuan Pharmaceutical Holdings Group Ltd (2.89 billion Chinese Renmimbi [US$414.02 million] of which 100% was Manufaturing and Sale of Pharmaceutical ).

Sales Analysis. During the year ended December of 2019, sales at Guizhou Bailing Group Pharmaceutical Company Limited were 2.85 billion Chinese Renmimbi (US$408.80 million). This is a decrease of 9.1% versus 2018, when the company's sales were 3.14 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 26.0% decline in Other, from 10.15 million Chinese Renmimbi to 7.50 million Chinese Renmimbi. There were also decreases in sales in Industry (down 12.1% to 2.40 billion Chinese Renmimbi) and Medical Institution (down 20.3% to 52.97 million Chinese Renmimbi) and Other Business (down 10.1% to 6.00 million Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Business (up 33.5% to 492.70 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Guizhou Bailing Group Pharmaceutical Company Limited
  Stock Performance Chart for Guizhou Bailing Group Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 9.35
(Figures in Chinese Renmimbi)
1 Week 6.9%   13 Weeks 10.5%  
4 Weeks 13.5%   52 Weeks 5.1%  
 
Guizhou Bailing Group Pharmaceutical Company Limited Key Data:
  Ticker: 002424 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 2,850,585,251
(Year Ending Jan 2020).
Employees: 5,961
  Currency: Chinese Renmimbi Market Cap: 13,194,720,000
  Fiscal Yr Ends: December Shares Outstanding: 1,411,200,000
  Share Type: A Gu Closely Held Shares: 869,863,267
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.